Unichem Laboratories Limited has received USFDA approval for its Carbamazepine Tablets

Unichem Laboratories Limited has declared that it has gotten ANDA endorsement for its Carbamazepine Tablets USP, 200 mg from the United States Food and Drug Administration (USFDA) to showcase a nonexclusive rendition of TEGRETOL (Carbamazepine) Tablet, 200 mg of Novartis Pharmaceuticals Corp.

Carbamazepine Tablets are demonstrated for use as an anticonvulsant drug and in the treatment of the aggravation connected with genuine trigeminal neuralgia. The item will be marketed from Unichem’s plant situated at Goa.

Unichem Laboratories is a drug organization. It tends to the requirements of remedial regions like gastroenterology, cardiology, diabetology, psychiatry, nervous system science, against bacterials, hostile to infectives and torment the board.

The organization announced merged total deficit of Rs 23.37 crore in Q1 FY23 as against total deficit of Rs 11.49 crore in Q1 FY22. Net deals rose 3.9% year on year to Rs 309.61 crore in the quarter finished 30 June 2022.


Corpradar is a next-gen digital IR 4.0 corporate media house that combines the power of technology with human capital to bring decisive and insight-driven content on key business affairs. In an absolute sense, we create a space for leading business houses and visionary corporate leaders to chime in with their opinions and thoughts on relevant industry-specific matters that provide a detailed expert perspective for our followers.

Leave a Reply

Your email address will not be published. Required fields are marked *